```json
{
"content": [
{
"type": "paragraph",
"content": "Valvuloplasty catheters are medical devices used to treat valve stenosis, offering a minimally invasive alternative to surgical interventions. As a critical component of interventional cardiology, the Valvuloplasty Catheter market is witnessing robust industry expansion driven by rising cardiovascular disease prevalence and technological innovation. The global Valvuloplasty Catheter market size reached $1.2 billion in 2025, reflecting a growth outlook of 6.5% CAGR from 2026 to 2033. Macro drivers include aging populations, advancements in balloon catheter design, and favorable regulatory frameworks for minimally invasive procedures. Key forces shaping the market include _technology shifts_ toward precision-based balloon catheters and _competitive intensity_ among key players like Boston Scientific and Medtronic."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Balloon Catheters", "Stent Delivery Systems", "Accessories"],
"periods": ["2021", "2022", "2023", "2024", "2025"],
"values": [
[10, 12, 14, 16, 18], // Balloon Catheters
[6, 7, 8, 9, 10], // Stent Delivery Systems
[4, 5, 6, 7, 8] // Accessories
]
}
},
{
"type": "paragraph",
"content": "North America dominates the market due to established healthcare infrastructure and high adoption of advanced catheterization techniques, while the Asia-Pacific region is the fastest-growing market, fueled by expanding medical tourism and government initiatives to reduce cardiovascular disease burdens. Strategic partnerships and R&D investments in _smart catheter technologies_ are expected to further accelerate the market forecast through 2033."
}
]
}
```
